A Xu, X Chu, S Zhang, J Zheng, D Shi, S Lv,
F Li… - BMC cancer, 2022 - Springer
Background The determination of HER2 expression status contributes significantly to HER2-
targeted therapy in breast carcinoma. However, an economical, efficient, and non-invasive …